Cambridge Healthtech Institute’s 29th Annual
Display and Discovery of Biologics
Imagining the Next Generation of Biologics
May 10-11, 2027
Phage, yeast, and mammalian display have been instrumental for generating therapeutic molecules against a wide range of diseases. The 29th Annual Display and Discovery of Biologics track is the leading track and cornerstone of the PEGS Boston Summit and brings together leaders to showcase emerging technologies and approaches to create novel formats and functionalities. Understanding the role of machine learning and AI to build and navigate repertoires and libraries is at the forefront of the field and accelerating the pace of discovery.
Coverage will include, but is not limited to:
- Discovering and designing new biologics including complex modalities, peptides, and mini-proteins with emerging platforms
- Selecting, optimizing, and developing biologics with phage and yeast display
- Tackling challenging targets with phage, yeast and mammalian display
- Applying quantitative yeast display
- Utilizing AI/ML techniques for efficient design and optimization of antibodies
- Expanding repertoires with machine learning-assisted directed evolution techniques to improve outcomes
The deadline for priority consideration is October 23, 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation:
- To submit a podium presentation, please click here.
- To become a sponsor, click here.
- To present a poster, click here.
- To sign up to attend, click here.